PALM Classification of Obstructive Sleep Apnea
The PALM classification represents four key physiological endotypes that drive OSA pathogenesis: Pcrit (pharyngeal critical closing pressure/upper airway collapsibility), Arousal threshold, Loop gain (ventilatory control stability), and Muscle responsiveness (upper airway dilator muscle function). 1
The Four PALM Components
P - Pcrit (Pharyngeal Critical Closing Pressure)
- Measures anatomical collapsibility of the upper airway
- Represents the pressure at which the pharynx passively collapses during sleep
- More positive Pcrit values indicate greater collapsibility
- In OSA patients, median Pcrit is 0.3 cm H₂O versus -6.2 cm H₂O in controls
- However, 19% of OSA patients have relatively non-collapsible airways (Pcrit -2 to -5 cm H₂O), similar to controls 1
A - Arousal Threshold
- Reflects how easily a patient awakens from sleep in response to respiratory stimuli
- 37% of OSA patients have a low arousal threshold, meaning they wake too easily before compensatory mechanisms can prevent apnea 1
- Low arousal threshold prevents upper airway muscles from adequately responding to obstruction
L - Loop Gain
- Quantifies ventilatory control system stability
- High loop gain indicates unstable breathing control with exaggerated ventilatory responses
- 36% of OSA patients have high loop gain 1
- In patients with non-collapsible airways (Pcrit -2 to -5 cm H₂O), loop gain is nearly twice as high (-5.9 vs -3.2), suggesting ventilatory instability drives their OSA 1
M - Muscle Responsiveness
- Measures the ability of upper airway dilator muscles (particularly genioglossus) to respond to obstruction during sleep
- 36% of OSA patients have minimal genioglossus muscle responsiveness 1
- Poor muscle compensation allows airway collapse despite neural drive
Clinical Significance
These traits vary substantially among patients, confirming OSA is heterogeneous rather than purely anatomical. 1 The research demonstrates:
- 28% of patients have multiple non-anatomic abnormalities 1
- Non-anatomic features play an important role in 56% of OSA patients based on a three-point weighting scale 1
- This framework enables phenotype-based individualized treatment rather than one-size-fits-all CPAP 2, 3
Measurement Approaches
PALM traits can be assessed through:
- CPAP pressure titration during sleep studies
- Esophageal pressure monitoring
- Advanced PSG signal analysis 2
The 2025 Chinese guidelines recommend considering endotyping using these four physiological traits to guide individualized treatment selection 2, though standardized clinical implementation remains evolving.
Treatment Implications
Different PALM profiles predict response to specific therapies:
- High loop gain → carbonic anhydrase inhibitors (acetazolamide, sultiame) 4
- Low arousal threshold → selected sedating agents 4
- Poor muscle responsiveness → noradrenergic-antimuscarinic combinations (AD109) 4
- High Pcrit/anatomical → CPAP, oral appliances, surgery 3
This endotypic framework represents the shift from AHI-based diagnosis to mechanism-based precision treatment of OSA. 1, 5